Hong Mingyang, Huang Xu, Zhu Huiming, Ma Jiahui, Li Feng
Department of Clinical Laboratory, Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong), Nantong, Jiangsu, China.
Nantong Institute of Genetics and Reproductive Medicine, Affiliated Maternity and Child Healthcare Hospital of Nantong University, Nantong, Jiangsu, China.
Front Immunol. 2025 Apr 16;16:1542686. doi: 10.3389/fimmu.2025.1542686. eCollection 2025.
Circular RNA (circRNA) is a new type of non-coding RNA that has gained significant attention in recent years, especially in tuberculosis research. Tuberculosis poses a major global public health threat. Its complex pathological mechanisms and worsening drug resistance urgently necessitate new research breakthroughs. The role of circRNA in mycobacterium tuberculosis infection is being gradually revealed, highlighting its importance in regulating gene expression, immune response, and inflammation. Additionally, researchers are interested in circRNA because of its potential for early tuberculosis diagnosis and its role as a biomarker. This article systematically analyzes existing literature to provide new insights into early tuberculosis diagnosis and personalized treatment. We also emphasize the need for future research to enhance the application of circRNA in tuberculosis prevention and control.
环状RNA(circRNA)是近年来受到广泛关注的一种新型非编码RNA,尤其是在结核病研究领域。结核病对全球公共卫生构成重大威胁。其复杂的病理机制和日益严重的耐药性迫切需要新的研究突破。circRNA在结核分枝杆菌感染中的作用正逐渐被揭示,凸显了其在调节基因表达、免疫反应和炎症方面的重要性。此外,由于circRNA在结核病早期诊断中的潜力及其作为生物标志物的作用,研究人员对其很感兴趣。本文系统分析现有文献,为结核病早期诊断和个性化治疗提供新的见解。我们还强调未来研究需要加强circRNA在结核病防控中的应用。